DEFA14A: BiomX Inc. Corrects Proxy Statement Ahead of Special Stockholder Meeting

BiomX Inc. issues a supplement to its definitive proxy statement to correct errors regarding stockholder voting eligibility and the number of Series X Preferred Stock shares outstanding.

Summary

• BiomX Inc. has filed a supplement to its definitive proxy statement related to the Special Meeting of Stockholders scheduled for April 21, 2025.
• The supplement corrects errors in the original proxy statement concerning which stockholders are eligible to vote on the proposals and the number of Series X Preferred Stock shares issued and outstanding as of the record date.
• The record date for determining stockholders entitled to vote at the Special Meeting remains March 17, 2025.
• The company clarifies that as of March 17, 2025, there were 24,966,053 shares of Common Stock issued and outstanding, with 18,176,661 entitled to vote on all matters.
• Additionally, there were 147,735 shares of Series X Preferred Stock issued and outstanding, none of which are entitled to vote on any matters at the Special Meeting.
• Stockholders who participated in the Offering can only vote on Proposal 1 with shares of Common Stock held prior to the Offering.
• Stockholders who did not hold shares of Common Stock prior to the Offering and received shares in the Offering cannot vote on Proposal 1.
• Each outstanding share of Common Stock is entitled to one vote on each matter considered at the Special Meeting.

Sentiment

Score: 7

Explanation: The document is a routine correction to a proxy statement, indicating a neutral to slightly positive sentiment as the company is ensuring accuracy and transparency.

Positives

• The company is proactively correcting errors in its proxy statement to ensure accurate information for stockholders.

Stakeholder Impact

• Shareholders are directly impacted by the corrected information regarding voting rights.
• Ensuring accurate proxy materials promotes fair and informed decision-making by stockholders.

Next Steps

• Stockholders should review the supplement and the original proxy statement before voting.
• Stockholders can access proxy materials at www.proxyvote.com.
• Stockholders who have already voted do not need to take action unless they wish to change their vote.

Key Dates

Keywords

Proxy Statement, Special Meeting, Stockholders, Voting Rights, Common Stock, Series X Preferred Stock, BiomX Inc.